We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Medgenics(Regs) | LSE:MEDG | London | Ordinary Share | COM SHS USD0.0001 (REGS) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 302.50 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
TIDMMEDG
RNS Number : 9707B
Medgenics Inc
04 November 2009
Medgenics, Inc.
('Medgenics' or the 'Company')
4 November 2009
It is with great sadness that the Company announces the death of Lord Leonard
Steinberg, Non-Executive Director, who died suddenly on the night of 2 November
2009.
Lord Steinberg served as a director of the Company since 1 February 2008 and the
Board would like to record its sincere gratitude for the valuable contribution
and support he gave to the Company during this period.
Andrew Pearlman, CEO, commented
"The whole of the Board are greatly shocked and saddened to learn of the
untimely death of Lord Steinberg, who was an invaluable member of our Board.
Lord Steinberg made an invaluable contribution to the continuing development of
Medgenics and supported the Company enormously over the last two years. He will
be greatly missed by everyone at the Company. Our sincere condolences go to his
wife and family at this sad time".
For further information, contact:
+----------------------------------------------------+---------------------------------------+
| Medgenics, Inc. | Phone: +972 4 902 8900 |
| Dr. Andrew L. Pearlman | |
| | |
+----------------------------------------------------+---------------------------------------+
| Grayling (Financial PR, UK) | Phone: +44 7900 053 536 |
| Jonathan Shillington | jonathan.shillington@uk.grayling.com |
| Alistair Scott | |
| | |
+----------------------------------------------------+---------------------------------------+
| Blomfield Corporate Finance Limited (Nominated | Phone: +44 207 444 0800 |
| Adviser) | |
| James Pinner | |
| Alan MacKenzie | |
| | |
+----------------------------------------------------+---------------------------------------+
| SVS Securities plc (Broker) | Phone: +44 207 638 5600 |
| Ian Callaway | |
| | |
+----------------------------------------------------+---------------------------------------+
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEZLFBKFBLFBX
1 Year Medgenics(Regs) Chart |
1 Month Medgenics(Regs) Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
